Related Experiment Video
Updated: Jun 8, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis
Kristiina Aalto1, Visa Honkanen, Pekka Lahdenne
1Helsinki University Central Hospital, University of Helsinki, Helsinki, HUS, Finland. kristiina.aalto@hus.fi
Insights
Anti-tumor necrosis factor (TNF) therapy improved hemoglobin and iron status in children with juvenile idiopathic arthritis (JIA). Serum transferrin receptor (sTfR) and TfR/log ferritin index (TfR/logF) are useful for assessing iron deficiency in these patients.
Area of Science:
- Pediatric Rheumatology
- Hematology
- Immunology
Background:
- Patients with active juvenile idiopathic arthritis (JIA) often experience low hemoglobin (Hgb) due to chronic inflammation and/or iron deficiency.
- Assessing iron status in JIA patients can be challenging due to inflammatory effects on iron markers.
Purpose of the Study:
- To evaluate the impact of anti-tumor necrosis factor (TNF) therapy on the iron status of children with active JIA.
- To determine the efficacy of anti-TNF agents in improving anemia and iron parameters in JIA.
Main Methods:
- A cohort of twenty children with JIA received either etanercept (n=8) or infliximab (n=12) for 12 months.
- Iron status was monitored using hemoglobin (Hgb), mean corpuscular volume (MCV), serum iron (sFe), ferritin, transferrin saturation (sTrfesat), and serum transferrin receptor (sTfR).
- The sTfR/log ferritin index (TfR/logF) was calculated to further assess iron deficiency.
Main Results:
- Anti-TNF therapy led to significant improvements in Hgb and MCV without iron supplementation.
- Serum iron (sFe) and transferrin saturation (sTrfesat) levels increased from low to normal ranges.
- Inflammation markers decreased, and serum transferrin receptor (sTfR) and TfR/logF were identified as reliable indicators of iron deficiency in this context.
Conclusions:
- Anti-TNF therapy effectively improves anemia and iron status in children with active JIA.
- Traditional iron deficiency markers (sFe, sTrfesat) may be unreliable in the presence of inflammation.
- Serum transferrin receptor (sTfR) and the TfR/logF index are valuable tools for diagnosing iron deficiency in JIA patients undergoing anti-TNF treatment.
Abstract:
Patients with active juvenile idiopathic arthritis (JIA) have frequently low haemoglobin (Hgb) due to inflammation and/or iron deficiency. The aim of the study was to evaluate the effect of anti-tumor necrosis factor (TNF) therapy on their iron status. Twenty children with JIA were treated with either etanercept (n = 8) or infliximab (n = 12) for 12 months. Iron status was assessed during anti-TNF treatment by Hgb, mean corpuscular volume of red blood cells (MCV), serum iron (sFe), ferritin, percent transferrin saturation (sTrfesat) and serum transferrin receptor concentration (sTfR). The sTfR/log ferritin index (TfR/logF) was also used. Prior to the therapy, Hgb and MCV were 118 ± 15.5 g/L and 79 ± 7.7 fl in the infliximab group, and 113 ± 12.5 g/L and 78 ± 5.8 fl in the etanercept group, respectively. In the whole group of patients, sFe was 6.3 ± 4.1 μmol/L and sTrfesat was 9% ± 6%. During anti-TNF therapy, Hgb and MCV improved significantly without use of iron supplementation, and sFe and sTrfesat increased from low to normal levels while inflammation markers decreased, except in one patient, in whom sTfR stayed elevated and the TfR/logF index value was high. In patients with active JIA associated with anaemia, low levels of sFe and sTrfesat cannot be used as markers for iron deficiency. In such patients, sTfR together with TfR/logF seem to be useful in assessing iron deficiency.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...